Parkinsonism & Related Disorders

Article	Citations
Supplemental ambient lighting intervention to improve sleep in Parkinson's disease: A pilot trial	94
Association between sebum secretion and cardiac sympathetic dysfunction in Parkinson's disease	88
Exploring the Nicotine-Parkinson's disease link – Insights from the UK Biobank	57
The effect of subjective postural vertical on forward flexed posture in Parkinson's disease	53
Glymphatic system in Pantothenase kinase associated neurodegeneration (PKAN)	49
Dopamine transporter imaging to predict the risk of aspiration in patients with Parkinson's disease	48
Acoustic prosodic parameters associated with Parkinson's disease cognitive impairment	46
Regression-based thresholds to detect clinical changes in verbal fluency after STN-DBS in Parkinson's disease	44
A case report of palatal tremor in progressive supranuclear palsy	43
Persons with Parkinson's disease show impaired interlimb coordination during backward walking	42
Huntington disease-like phenotype in a patient with ANO3 mutation	41
Increasing Parkinson's disease related mortality through the pandemic and beyond: An update	41
Is heart rate variability the heart of the matter for freezing of gait?	40
Speech-in-noise hearing impairment is associated with increased risk of Parkinson's: A UK biobank analysis	40
Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's disease	39
“Accidental, really?” Attributional bias in patients with Parkinson's disease	39
Non-motor effects of deep brain stimulation in Parkinson's disease motor subtypes	36
Soluble LAG-3 and Toll-interacting protein: Novel upstream neuro-inflammatory markers in Parkinson's disease	35
Genetic etiology of a Chinese ataxia cohort: Expanding the mutational spectrum of hereditary ataxias	34
Subacute hemichorea and asymmetrical basal ganglia abnormalities: An archetypal scenario for anti-CV2 encephalitis	34
Working memory, attention and planning abilities in NKX2.1-related chorea	33
Combined CSF α-SYN RT-QuIC, CSF NFL and midbrain-pons planimetry in degenerative parkinsonisms: From bedside to bench, and back again	32
Early-onset levodopa responsive parkinsonism in PPP2R5D mutation	31
Efficacy and safety of foslevodopa/foscarbidopa continuous subcutaneous infusion administered as monotherapy in patients with Parkinson’s disease	31
Estimating the sequence of biomarker changes in Parkinson's disease	31

Interdisciplinary insights into tremor in dystonia: Navigating clinical controversies, definitional challenges, and pathophysiological complexities	31
Saving dopaminergic neurons from endoplasmic reticulum (ER) stress - A breakthrough approach to fight Parkinson's disease	30
Is Dystonia an Immunologic Disorder?	30
Interaction between sex and GBA mutations influences clinical phenotype in Parkinson disease	29
Are peripheral α-synuclein isoforms biomarkers for diagnosis and prognosis of isolated REM sleep behavior disorder?	26
Neuroprotective potential of nanoparticles of cinnamaldehyde on oxidative stress in nigrostriatal tissue and neurobehavioral characteristics in a rat model of Parkinson’s disease	26
Novel insights into the sex-specific role of lipid and apolipoprotein traits associated with risk of Parkinson’s disease: A prospective study	25
Integrity of Dopaminergic Terminals in the Caudate Nucleus Modulates Rest Tremor in Parkinson’s Disease	25
Role of linagliptin, a dipeptidyl peptidase-4 inhibitor against oxidative stress and neuronal damage in experimental diabetic aging brain of female rats of different age groups.	25
Withdrawn	24
The significance of mineral mass imbalances in cognitive dysfunctions associated with vascular parkinsonism	23
β-Caryophyllene decreases neuroinflammation and exerts neuroprotection of dopaminergic neurons in a model of hemiparkinsonism through inhibition of the NLRP3 inflammasome	23
Brain metabolic correlates of STN-DBS on gait in Parkinson’s disease: FDG-PET study of gait with dynamic obstacle avoidance	23
Dancing Out of Step: A Case of Tuberculous Meningitis Disguised as Childhood Chorea	23
Gender, Race and Socioeconomic Disparities on Initiation of Surgical Device-Aided Therapies (DATs) Among Medicare Beneficiaries with advanced Parkinson’s Disease (aPD)	23
Pallidal Deep Brain Stimulation for Patients with Idiopathic Myoclonus Dystonia without SGCE Mutation	22
Parkinson's Disease Social Stigma Perception Scale (PDSP): Development and Pilot Study Of A Measurement Scale	22
The Association of Radiological Features to Predominant Cognitive Clinical Syndromes of Lewy Body Dementia	22
The association of olfactory dysfunction with depression in patients with early-onset Parkinson`s disease	22
‘Hung-up’ knee jerk as an initial diagnostic clue of Huntington disease	22
Optimizing DBS-Programming: A Case Study with Algorithm-Guided Strategies in Parkinson's Disease	22
Integrity of Dopaminergic Terminals in the Caudate Nucleus Modulates Rest Tremor in Parkinson’s Disease	22
NOX1 triggers ferroptosis and ferritinophagy, contributing to neurodegeneration	21
Addressing Brain Circuit Dysfunction Underlying DBS-induced Parkinsonism	21
Essential Tremor Diagnosis Accuracy: 1998 versus 2018 Movement Disorder Society Consensus	21
Dopaminergic System Changes in Visuomotor-Cognitive Multitasking Simulating Real-Life Mobility in Parkinson’s Disease	21
Progressive Encephalomyelitis with Rigidity and Myoclonus in a Varicella Encephalitis patient with Primary Meige syndrome	20
Sporadic Creutzfeldt-Jakob disease: A Retrospective Analysis of 27 cases in Vietnam	20
Occupational impact of tardive dyskinesia (TD): Survey assessing perceptions and experiences of patients with TD and physicians who treat TD	20
Executive function in patients with Parkinson disease	20
Psychomotor delay: Expanding the neurological phenotype of ATP13A2-related disorders	20
Sleep Biomarker-Based Characterization of Neurodegenerative Disorder Risk in Parkinsonian Spectrum Disorder Patients	20
Speech Biomarkers for Dysarthria in Parkinson's Disease — Clinical Validation Across Spanish and Czech Languages	20
Genetically Proven Familial Huntington’s Disease in the Philippines: A Case Series	20
Opicapone as First-Line Strategy for the Treatment of Wearing-off in Patients with Parkinson's Disease	20
Association between serum lipid levels and dopamine loss in idiopathic rapid eye movement sleep behavior disorder	20
“Pop-up” studies: Observational studies in Huntington disease conducted at annual family convention	20
Characterization of movement disorders in a cohort of hereditary cerebellar ataxias	20
Cognitive compromise in a cohort of patients from Colombia with DBS for Parkinson's disease treatment	20
Mental health in Parkinson’s: Uncovering real-world patient experiences in psychological support and care	19
Quality of Life in Parkinson’s Disease: Examining the Influence of the Intersection between Health-Related Quality of Life and Clinical Metrics	19
CVN424, A novel GPR6 inverse agonist for the treatment of Parkinson disease (PD): Phase 2 clinical trial	19
Digital devices and wearable technology for quantification of freezing of gait in adolescents with pediatric movement disorders attending school	18
Can Baseline Diffusion Tensor Imaging Analysis Along the Perivascular Space Predict Motor Progression at 5 Years in Parkinson Disease?	18
Community-based participatory research approach to address health care disparities confronting members of the Black Diaspora with Parkinson’s disease	18
An observational study of Quality of Life in patients with Parkinson’s Disease pre and post DBS	18
Fibrinogen exacerbates GCase ubiquitination via ATF5-induced TRIP12 activation in Parkinson's Disease	17
Parkinson’s Disease Management in a Tertiary Irish Hospital	17
Profile of Glucocerebrosidase 1 (GCASE) activity and Glucosylsphingosine levels in GBA-PD, PD patients and healthy volunteers	17
Role of pharmacological therapy on bone mineral density and postural instability in post-menopausal women with Parkinson’s disease	17

Improving Quality and Safety of Care for Hospitalized People with Parkinson’s Disease – Results of Six Months of Proactive Intervention	17
Characterizing Pain in Parkinson's Disease: Unveiling Types and Underlying Pathophysiology through a Scoping Review	17
Quebec Parkinson Network: The reference for your next research in Parkinson's disease and related disorders	17
Right Default Mode Network Functional Instability Predicts Poorer Executive Function in Parkinson’s Disease	17
The Correlation between Nutritional Status and Quality of Life in Persons with Parkinson’s disease	17
Continuous subcutaneous levodopa/carbidopa infusion (ND0612) for patients with Parkinson’s disease and motor fluctuations: A Phase 3, active-controlled study (BouNDless)	17
Role Of Wearable Technology And Geo-Fencing Device For Analyses of Movement And Memory Data In Huntington's Disease Patients In Gurugram City, India	16
Association and Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson’s Disease–related Cognitive Impairment	16
Impact of Rivastigmine on Gait in Patients with Neurodegenerative Disorders: A Systematic Review and Meta-analysis	16
Targeting sedentary behavior decreases depressive symptoms and improves sleep in people with Parkinson’s Disease	16
Association of Baseline Serum Urate Levels with Longitudinal General Cognition in Non-Demented Parkinson's Disease	16
An unusual cause of gait disturbance in a patient with Parkinson’s disease: Beware of mimics and chameleons	16
Therapeutic effects of hyperbaric oxygen on Parkinson disease - A systematic review and meta-analysis.	16
Chorea-Acanthocytosis: A Case Report	16
Emerging role of rolipram in orofacial dyskinesia in a haloperidol-induced rat model via downregulation of oxidative stress and alteration in neurotransmitters	16
Unawareness of hyposmia in people with and without Parkinson`s disease	16
Absence of causal relationship between Parkinson’s disease and subsequent prostate cancer: Evidence from meta-analysis and Mendelian randomization studies	15
Study of the Neuroprotective Potential of gallic acid in the Mouse Model of Parkinson’s Disease	15
Acute effect of levodopa on orthostatic hypotension and its association with motor responsiveness in Parkinson's disease	15
Relation between Clinical and Electrophysiological Correlates of Peripheral Polyneuropathy and Oral Levodopa Treatment in People with Parkinson’s Disease	15
Observational study of Safinamide as an add-on to levodopa monotherapy for Parkinson's disease patients with wearing-off in Japan	15
Longitudinal change in brain function and structure related to plasma neurofilament light protein in early-stage Parkinson’s disease	15
Examination of cognitive function in Parkinson's disease patients with chronic kidney disease	15
Neurovascular conflict in primary hemifacial spasm: A radiological topographic and severity assessment of contact	15
A novel ANO3 variant in two siblings with different phenotypes	14
Unveiling the nexus: Understanding post-COVID parkinsonism and its neurological ramifications	14
Parkinsonism in people with intellectual disability	14
The therapeutic effects of multimodal exercise for people with Parkinson's: A longitudinal community-based study	14
Anosognosia in HD: Comparison of self-report and caregiver ratings with objective performance measures	14
Magnetic resonance spectroscopy reveals evidence of brain oxidative stress in Tourette syndrome	14
Complex motor tics and neurobehavioral syndrome in diencephalic-mesencephalic junction dysplasia: Association or causation?	14
Establishing a framework for quality of inpatient care for Parkinson's disease: A study on inpatient medication administration	14
Digital health technology for non-motor symptoms in people with Parkinson's disease: Futile or future?	14
A useful cognitive motor dual task paradigm in prodromal and manifest Huntington’s disease	14
Objective sleep enhancement in Parkinson's disease: A sham-controlled trial of low-frequency repetitive transcranial magnetic stimulation over the right dorsolateral prefrontal cortex	14
Imaging-based DBS programming help: Does it help?	14
Clinical neurophysiology for tremor: Common questions in clinical practice	14
Machine learning trained with quantitative susceptibility mapping to detect mild cognitive impairment in Parkinson's disease	13
Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson disease	13
Cognitive impairment in REM-sleep behaviour disorder and individuals at risk of Parkinson's disease	13
Retinal microvascular impairment in Parkinson's disease with cognitive dysfunction	13
Neuroinflammation in Parkinson’s disease: A study with [11C]PBR28 PET and cerebrospinal fluid markers	13
Bilateral Hemimasticatory spasm in a patient with hypereosinophilic syndrome	13
Sonographic vagus nerve atrophy in Parkinson's disease: Myth or fact? A systematic review and meta-analysis of recent evidence answers	13
Neuropsychological outcomes after thalamic deep brain stimulation for essential tremor	13
Hemiatrophy-hemiparkinsonism and Poland syndrome: A causative or coincidental association?	13
A case report of acute thrombocytopenia induced by Apomorphine in a patient with Parkinson's disease with motor fluctuations	13
Genetic landscape of Segawa disease in Spain. Long-term treatment outcomes	13
Are there morphological differences between Parkinson's disease-dementia and dementia with Lewy bodies?	13
Increased brain cholinergic innervation in isolated REM sleep behaviour disorder from prodromal multiple system atrophy	13
Effects of rhythmic auditory stimulation on upper-limb movements in patients with Parkinson's disease	13
Validation of a Parkinson's disease questionnaire-39-based functional mobility composite score (FMCS) in people with Parkinson's disease	13
Genetic screening of Filipinos suspected with familial Parkinson's disease: A pilot study	13
Fear among patients with Parkinson's disease and repeated falls: Analysis of skin conductance responses during simulated accidents	13
Trajectory of change in body mass index in Parkinson's disease	13
Characterization and diagnostic potential of diffusion tractography in multiple system atrophy	13
OFF episode quality of life impact scale (OFFELIA): A new measure of quality of life for off episodes in Parkinson's disease	12
The p.Val234Met LRP10 likely pathogenic variant associated with Parkinson's disease: Possible molecular implications	12
Short-term cognitive practice effects in Parkinson's disease: More than meets the eye	12
Incidence and risk factors of institutionalisation in Parkinson's disease and atypical parkinsonism	12
Buried Bumper Syndrome is not caused by levodopa infusion. Reply to Dr Kotzampassi's Letter to the Editor. Concerning the publication: Buried Bumper Syndrome: A common complication of levodopa intesti	12
Editorial Board	12
Subthalamic deep brain stimulation improves vascular endothelial function in Parkinson's disease	12
Hope vs. Hype II: It is time to offer pre-symptomatic genetic testing for GBA and LRRK2 variants	12
Aberrant visual-related networks in familial cortical myoclonic tremor with epilepsy	12
OFF-times before, during, and after nighttime sleep periods in Parkinson's disease patients with motor fluctuations and the effects of opicapone: A post hoc analysis of diary data from BIPARK-1 and -2	12
A case of senile-onset progressive hemiballism and cognitive decline with diffuse brain iron accumulations	12
Putaminal T1/T2-weighted ratio is increased in PSP compared to PD and healthy controls, a multi-cohort study	12
Rhythmic auditory stimulation as a potential neuromodulator for Parkinson's disease	12
Prevalence and impact of mental health issues in Parkinson's disease unplanned hospital admissions	12
Living with chronic illness scale in Parkinson's disease: Longitudinal metric properties and meaningful change	12
Cerebrospinal fluid neuropathological biomarkers in beta-propeller protein-associated neurodegeneration, with complicated parkinsonian phenotype	12
Imaging biomarkers for early multiple system atrophy	12
Disease severity and prefrontal cortex activation during obstacle negotiation among patients with Parkinson's disease: Is it all as expected?	12
Regional cerebral cholinergic vesicular transporter correlates of visual contrast sensitivity in Parkinson's disease: Implications for visual and cognitive function	12
Correlation between clinical and neuropathological subtypes of progressive supranuclear palsy	12
Associations of cerebrospinal fluid monoamine metabolites with striatal dopamine transporter binding and 123I-meta-iodobenzylguanidine cardiac scintigraphy in Parkinson's disease: Multivariate analyse	12
Shannon entropy: A novel parameter for quantifying pentagon copying performance in non-demented Parkinson's disease patients	12
Autonomic dysregulation during sleep in Parkinsonian spectrum disorders - A proof of concept	12
Pallidal neuronal activity in multiple system atrophy type P and Parkinson's disease	12

Tai Chi improves non-motor symptoms of Parkinson's disease: One-year randomized controlled study with the investigation of mechanisms	12
Flattened red nucleus in progressive supranuclear palsy detected by quantitative susceptibility mapping	12
Quantitative digital clock drawing test as a sensitive tool to detect subtle cognitive impairments in early stage Parkinson's disease	12
Helicobacter pylori infection is a risk factor for constipation in patients with Parkinson's disease: A multicenter prospective cohort study	12
Editorial Board	11
The multimodal effect of circadian interventions in Parkinson's disease: A narrative review	11
Diet quality and prodromal Parkinson's disease probability in isolated REM sleep behavior disorder	11
Goodbyes, thank you, and cutting cake…	11
Characteristic of impulse control disorders in Polish patients with Parkinson's disease	11
Diagnosis of vascular parkinsonism: A new tool for gait hypokinesia occurring in older persons	11
Rare neurological indications for Deep Brain Stimulation treatment: experience at the University Medical Center Ljubljana	11
Cognition in children and young adults with myoclonus dystonia – A case control study	11
Correlation between NREM Sleep EEG characteristics and Mild Cognitive Impairment in patients with Parkinson’s disease	11
Reply to the Letter to the Editor: “Do not biopsy the MELAS brain”	11
The auditory startle response in relation to outcome in functional movement disorders	11
Peribuccal and pharyngeal myorhythmia as a presenting symptom of hypertrophic olivary degeneration: Expert commentary	11
The impact of lockdown on Functional Motor Disorders patients during the first COVID-19 outbreak: acase-control study	11
Addressing critical care gaps in inpatient Parkinson's care – Minimizing the impact of comorbidities and developing new care delivery models	11
Long-term neuropsychological outcomes of deep brain stimulation in early-stage Parkinson's disease	11
Case Reports and Movement Disorder Rounds: Learning through observation, building on collective experiences	11
Characterization and localization of upper and lower extremity motor improvements in STN DBS for Parkinson's disease	11
Correlation of hypothalamic-pituitary adrenal disorders with cognitive impairment in Parkinsons disease and vascular parkinsonism	11
White matter connectivity networks predict early dementia conversion in Parkinson’s disease	11
Evaluation of extrapyramidal diseases with Parkinson’s disease in patients suffering from stroke in Tashkent region, Uzbekistan	11
Lighthouse in the open sea of spastic ataxia; what are the features that should not be missed in SPG11?	11
Subacute tremor and ataxia: Diligence in pursuit of a diagnosis: Expert commentary	11
If not insulin resistance so what? Comparison fasting glycaemia in idiopathic Parkinson's disease and atypical parkinsonism	11
Editorial Board	11
ParkinsonGoesDTx – a novel gait monitor concept triggers treatment decisions in Parkinson’s disease	11
Different types of tremor and myoclonus in an atypical case of shaking upon standing: Expert commentary	11
Morbidity and severity of COVID-19 in patients with Parkinson's disease treated with amantadine	11
Editorial Board	11
Identification of suboptimal response to STN-DBS in Parkinson’s disease	11
Alterations in the HSP70 system in PBMC accompanying Parkinson's disease	10
Critical Appraisal of Economic Evaluation of Biomarkers Used for Screening of Dementia	10
Apomorphine sublingual film for “OFF” episodes in Parkinson’s disease: long-term safety and efficacy	10
Dystonia 23: first report of a Colombian case	10
Vestibular dysfunction: which is the effects of virtual reality?	10
IncobotulinumtoxinA injections at intervals <10 weeks are effective and safe for cervical dystonia patients with inadequate benefit from standard intervals	10
Common pitfalls in recognition of an age old malady: edentulous stereotypy	10
How choroidal thickness is related with Parkinson’s disease? A case control study	10
Hemorrhagic risk in patients who undergo deep brain stimulation on chronic antiplatelet or anticoagulation therapy	10
Non-permitted food colorants induced cognitive impairment and neurotoxicity in hippocampus of rats	10
EEG findings in Gilles de la Tourette syndrome	10
Population pharmacokinetics of levodopa and carbidopa following subcutaneous infusion	10
Heads - It's Parkinson’s; tails - it's cancer, a kindred of Parkinsonism and Malignancies	10
Neuroprotective and antioxidant potential of Moringa oleifera leaf extract in a murine model of Parkinson's disease	10
OCT in Parkinson disease	10
Apomorphine sublingual film for “OFF” episodes in Parkinson’s disease: analysis of baseline factors	10
Early onset hemichorea-parkinsonism with POLG mutation without external ophthalmoplegia responsive to pallidal DBS	10
Study of the difficulties of late diagnostics in patients with Huntington’s disease in Uzbekistan	10
Feasibility and efficacy of video-call speech therapy in patients with Parkinson's disease: A preliminary study	10
Progressive Supranuclear Palsy Parkinsonism-Predominant (PSP-P) – a problematic entity in the examination of parkinsonisms	10
L-Dopa responsiveness in Perry syndrome (parkinsonism, depression, weight loss, hypoventilation)	10
Non-motor symptoms in cervical dystonia	9
Fears and certainties of chilean neurologists in the therapeutic approach to parkinson's disease	9
Abnormal cortical excitability in patients with spinocerebellar ataxia type 12	9
Impaired virtual space-tilting perception in Parkinson's disease with Pisa syndrome	9
Early-onset Parkinson's disease with atypical molecular imaging abnormalities in a patient carrying the de novo PRKCG mutation	9
A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study	9
PINK1-PD: A compound heterozygote of Filipino ancestry and 7 Tesla MRI findings	9
A novel summary index derived from Kinect to evaluate the severity of postural abnormalities in patients with Parkinson’s Disease	9
Malnutrition status and cognitive functions correlation in patients with Parkinson's disease and atypical parkinsonisms: a preliminary study	9
Polysomnographic study: characteristics of sleep disturbances in patients with Parkinson's disease	9
Video-based analysis of gait in Parkinson disease	9
Feasibility of large-scale systematic data collection in a quality improvement registry of deep brain stimulation in Parkinson’s disease	9
“Watch out for the break in the dam”: Is Aquaporins dysfunction the missing link between immune dysregulation, glia activation, and neurodegeneration?	9
Intrafamilial and interfamilial heterogeneity of PINK1-associated Parkinson's disease in Sudan	9
Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy	9
North American survey on impact of the COVID-19 pandemic shutdown on DBS care	9
Excessive daytime sleepiness in Parkinson's disease: A systematic review and meta-analysis	9
Characteristics of tics in follow-up study of community-based high risk cohort of 2511 children	9
Model of virtual communication of the Reference center for invasive methods of treatment of Parkinson's disease during the COVID-19 pandemic	9
Comparison of patient preferences for Parkinson’s disease treatments and reductions in OFF-time	9
Clinical presentation and diagnosis of a rare brain disease – progressive supranuclear palsy	9
Whole exome sequencing of familial, combined or complex dystonia	9
Leigh-like syndrome as a presentation of biallelic variants in DNAJC30 gene with predominant putamen degeneration and limb dystonia	9
Glutamate cycle changes in the putamen of patients with de novo Parkinson's disease using 1H MRS	9
Genetic architecture of a single cohort of 230 Indian Parkinson's Disease patients	9
Episodic ataxia in child with 16p11.2 deletion including PRRT2	9
A multimodal meta-analysis of structural and functional brain changes in idiopathic blepharospasm	9
Genetic heterogeneity on sleep disorders in Parkinson’s disease: a systematic review and meta-analysis	9
Peribuccal and pharyngeal myorhythmia as a presenting symptom of hypertrophic olivary degeneration	8
Composite measures of motor performance and self-efficacy are better determinants of postural instability and gait difficulties than individual clinical measures in Parkinson's disease	8
Accuracy and precision of wrist-worn actigraphy for measuring steps taken during over-ground and treadmill walking in adults with Parkinson's disease	8
People with Parkinson's report increased impulse control behaviours during the COVID-19 UK lockdown	8
Parkinson's disease progression is multifaceted: Evidence for the underlying benchmarks	8
Longitudinal brain changes in Parkinson's disease with severe olfactory deficit	8
Dysfunction of human brain network hierarchy in Parkinson's disease patients with freezing of gait	8
Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta-analysis, and meta-regression	8
Quantitative susceptibility mapping analyses of white matter in Parkinson's disease using susceptibility separation technique	8
Regional gray matter volumes are not predictive of axial symptom response to subthalamic deep brain stimulation in Parkinsonian patients	8
Visual and vestibular integration in Parkinson's disease while walking	8
Prefrontal network dysfunctions in rapid eye movement sleep behavior disorder	8
Association of lipid levels with motor and cognitive function and decline in advanced Parkinson's disease in the Mark-PD study	8